RESUMEN
Mexican wolves (Canis lupus baileyi), classified as probably extinct in the wild in Mexico and endangered in the US, were reintroduced into Arizona in 1998. We combined annual serologic testing results from samples collected between 2003 and 2016 from 108 wolves and known survival data from 118 wolves born in the recovery area from 2003 to 2014 to evaluate whether exposure to canine distemper virus (CDV) or canine parvovirus (CPV) was associated with a greater risk of mortality before 2 yr of age. We used mixed-effects logistic regression to estimate the effect of CDV and CPV on the probability of mortality. Annual seroprevalence rates for CDV and CPV ranged from 0% to 62% and from 33% to 100%, respectively (median, 14.2% and 90.3%, respectively). The covariate, age at testing, had a negative effect on mortality, indicating that younger animals had lower survival, whereas sex had little effect on mortality. The best-supported model excluded any effect of CPV or CDV on death before 2 yr old at both the pack and individual level. Although our analysis did not detect an effect of these viruses on mortality before 2 yr old, CDV was later identified as the cause of mortality in two individuals in 2017. Additional information is needed to assess the impact of these diseases on Mexican wolves.
Asunto(s)
Virus del Moquillo Canino , Moquillo/virología , Infecciones por Parvoviridae/veterinaria , Parvovirus Canino , Lobos/virología , Animales , Moquillo/epidemiología , Moquillo/mortalidad , Especies en Peligro de Extinción , Infecciones por Parvoviridae/epidemiología , Infecciones por Parvoviridae/mortalidad , Infecciones por Parvoviridae/virología , Estudios Seroepidemiológicos , Estados Unidos/epidemiologíaRESUMEN
Distemper disease is an infectious disease reported in several species of domestic and wild carnivores. The high mortality rate of animals infected with canine distemper virus (CDV) treated with currently available therapies has driven the study of new efficacious treatments. Mesenchymal stem cell (MSC)-based therapy is a promising therapeutic option for many degenerative, hereditary, and inflammatory diseases. Therefore, the aim of this study was to characterize stem cells derived from the canine fetal olfactory epithelium and to assess the systemic response of animals infected with CDV to symptomatic therapy and treatment with MSCs. Eight domestic mongrel dogs (N = 8) were divided into two groups: support group (SG) (N = 5) and support group + cell therapy (SGCT) (N = 3), which were monitored over 15 days. Blood samples were collected on days 0, 6, 9, 12, and 15 to assess blood count and serum biochemistry (urea, creatinine, alanine transferase, alkaline phosphatase, gamma-glutamyl transferase, total protein, albumin, and globulin), and urine samples were obtained on days 0 and 15 for urinary evaluation (urine I). The results showed a high mortality rate (SG = 4 and SGCT = 2), providing inadequate data on the clinical course of CDV infection. MSC therapy resulted in no significant improvement when administered during the acute phase of canine distemper disease, and a prevalence of animals with high mortality rate was found in both groups due to the severity of symptoms.